itraconazole has been researched along with Carcinoma, Hepatocellular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celik, OI; Çetin, ES; Cigerci, IH; Sozen, H; Yılmaz, N | 1 |
| Dong, X; Liu, Y; Ni, B; Ni, J; Qu, C; Sai, N; Sun, M; Wang, W; Yao, Y; Yin, X; You, L | 1 |
| Brocks, DR; El-Kadi, AO; Korashy, HM; Shayeganpour, A | 1 |
| Brocks, DR; El-Kadi, AO; Korashy, HM | 1 |
4 other study(ies) available for itraconazole and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Mistletoe (Viscum album L.) extract attenuates ıtraconazole-ınduced acute oxidative stress and hepatocellular ınjury in rats.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Female; Itraconazole; Liver; Liver Neoplasms; Mistletoe; Oxidants; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Viscum album | 2023 |
Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Itraconazole; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Wnt Signaling Pathway | 2020 |
Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines.
Topics: Animals; Antifungal Agents; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Genes, Reporter; Humans; Itraconazole; Ketoconazole; Liver Neoplasms; Luciferases; Mice; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic | 2007 |
Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: a mechanism of cancer chemoprotection.
Topics: Animals; Antifungal Agents; Carcinoma, Hepatocellular; Enzyme Activation; Enzyme Induction; Fluconazole; Itraconazole; Ketoconazole; Liver Neoplasms, Experimental; Mice; NAD; NAD(P)H Dehydrogenase (Quinone); Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 2007 |